Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Mono Pharmacare Ltd
Mono Pharmacare Ltd

Mono Pharmacare Ltd (MONOPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 10,000
Dec 05, 2025
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹18.95
₹-0.05 (-0.26%)
18.95Low
Today’s Performance
18.95High
18.90Low
52 Week’s Performance
36.20High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-%
  • 1 Week-14.06%
  • 1 Month-7.56%
  • 3 Months-12.06%
  • 6 Months-25.39%
  • 1 Year-47.51%
  • 3 Years-14.62%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.41
  • 52-Week Low (₹)18.90
  • 52-Week High (₹)36.20
  • Price-to-Book (X)*1.07
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*10.77
  • Earnings Per Share (₹)1.76
  • Market Cap (₹ Cr.)*33.48
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Mono Pharmacare Ltd share price previously?
Mono Pharmacare Ltd share price was down by -0.26% from the previous closing price of ₹19.00.
Who are peers of Mono Pharmacare Ltd?
The peers of Mono Pharmacare Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Mono Pharmacare Ltd?
The promotor/promotors of Mono Pharmacare Ltd are Panilam Lakhatariya, Supal Lakhatariya, Archit Shah, Chintan Trivedi, Rahul Joshi, Jitendra Mansukhlal Dasani, Drashti Rohit Chande.
What has been 52-week high of Mono Pharmacare Ltd stocks?
The highest price of Mono Pharmacare Ltd stock is ₹36.20 in the last 52-week.
What is the share price of Mono Pharmacare Ltd (MONOPHARMA) today on NSE?
As on Dec 05, 2025 Mono Pharmacare Ltd (MONOPHARMA)’s share price on NSE is Rs 18.95
What is the market cap of Mono Pharmacare Ltd (MONOPHARMA)?
The current market capitalisation of Mono Pharmacare Ltd (MONOPHARMA) is 33.48 crores
What is Mono Pharmacare Ltd Share symbol?
The symbol of Mono Pharmacare Ltd is MONOPHARMA.
What is the PE ratio of Mono Pharmacare Ltd (MONOPHARMA)?
The current PE ratio of Mono Pharmacare Ltd (MONOPHARMA) is 10.77.
What is the PB ratio of Mono Pharmacare Ltd (MONOPHARMA)?
The current PB ratio of Mono Pharmacare Ltd (MONOPHARMA) is 1.07.
Today’s High & Low share prices of Mono Pharmacare Ltd (MONOPHARMA) on NSE?
Today, the share price of Mono Pharmacare Ltd (MONOPHARMA) on NSE touched a high of Rs 18.95 and a low of Rs 18.95
What price did Mono Pharmacare Ltd (MONOPHARMA) shares open on the NSE today?
On NSE, the share price of Mono Pharmacare Ltd (MONOPHARMA) opened at Rs 18.95
What is the 52-week high of Mono Pharmacare Ltd (MONOPHARMA)?
The 52-week high price of Mono Pharmacare Ltd (MONOPHARMA) is Rs 36.20
What is the 52-week low of Mono Pharmacare Ltd (MONOPHARMA)?
The 52-week low price of Mono Pharmacare Ltd (MONOPHARMA) is Rs 18.90

bt_logoAbout Mono Pharmacare

Mono Pharmacare Ltd, incorporated in the year 2022, has its registered office in 1A Krinkal Apartment opp, Mahalaxmi Temple Paldi, Ahmedabad, Gujarat, 380007, +91-99780 41356. The main industry in which Mono Pharmacare Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Mono Pharmacare Ltd is/are Kumbhat & Co. In the main management, is chairman and Rahul Joshi is the company secretary for Mono Pharmacare Ltd.

  • PL
    Panilam LakhatariyaManaging Director
  • SL
    Supal LakhatariyaExecutive Director
  • AS
    Archit ShahExecutive Director
  • CT
    Chintan TrivediIndependent Director
  • RJ
    Rahul JoshiCompany Sec. & Compli. Officer
  • JMD
    Jitendra Mansukhlal DasaniIndependent Director
  • DRC
    Drashti Rohit ChandeAdditional Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.